DR REDDYS LABS ADR/1 IR 5
Certificat de dépôt · US2561352038 · RDY · 659157 (XNYS)
15,54 USD
06.06.2025 19:59
Cours actuels de DR REDDYS LABS ADR/1 IR 5
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NYSE |
RDY
|
USD
|
06.06.2025 19:59
|
15,54 USD
| 15,53 USD
+0,06 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | 5,64 % | 14,94 % | 20,05 % | 6,58 % | 8,88 % | -70,70 % |
Profil de l'entreprise pour DR REDDYS LABS ADR/1 IR 5 Certificat de dépôt
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Données de l'entreprise
Nom DR REDDYS LABS ADR/1 IR 5
Société Dr. Reddy's Laboratories Limited
Symbole RDY
Site web
https://www.drreddys.com
Marché d'origine
NYSE

WKN 659157
ISIN US2561352038
Type de titre Certificat de dépôt
Secteur Healthcare
Industrie Drug Manufacturers - Specialty & Generic
PDG Mr. Erez Israeli M.B.A.
Capitalisation boursière 11 Mrd.
Pays Inde
Devise USD
Employés 27,0 T
Adresse 8-2-337, Road No. 3, 500034 Hyderabad
Date d'introduction en bourse 2001-04-11
Fractionnements d'actions
Date | Fractionnement |
---|---|
05.11.2024 | 5:1 |
07.09.2006 | 2:1 |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | RDDA.F |
NYSE | RDY |
Autres actions
Les investisseurs qui détiennent DR REDDYS LABS ADR/1 IR 5 ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.